4.8 Review

Function of oncogenes in cancer development: a changing paradigm

Journal

EMBO JOURNAL
Volume 32, Issue 11, Pages 1502-1513

Publisher

WILEY
DOI: 10.1038/emboj.2013.97

Keywords

cancer stem cell; cancer therapy; mouse model; oncogenes; tumoural reprogramming

Funding

  1. FEDER
  2. MICINN [SAF2012-32810]
  3. MEC OncoBIO Consolider-Ingenio [CSD2007-0017]
  4. NIH grant [R01 CA109335-04A1]
  5. ARIMMORA project (FP7-ENV, European Union Seventh Framework Program)
  6. proyecto en red de investigacion en celulas madre tumourales
  7. Obra Social Kutxa y Conserjeria de Sanidad de la Junta de Castilla y Leon
  8. institutional grant from the Fundacion Ramon Areces
  9. European Union FEDER program

Ask authors/readers for more resources

Tumour-associated oncogenes induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, therapeutic strategies that block oncogene activity are likely to selectively target tumour cells. However, recent evidences have revealed that oncogenes are only essential for the proliferation of some specific tumour cell types, but not all. Indeed, the latest studies of the interactions between the oncogene and its target cell have shown that oncogenes contribute to cancer development not only by inducing proliferation but also by developmental reprogramming of the epigenome. This provides the first evidence that tumorigenesis can be initiated by stem cell reprogramming, and uncovers a new role for oncogenes in the origin of cancer. Here we analyse these evidences and propose an updated model of oncogene function that can explain the full range of genotype-phenotype associations found in human cancer. Finally, we discuss how this vision opens new avenues for developing novel anti-cancer interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available